Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
COCP
#3809
Cocrystal Pharma, Inc. Common Stock
1.0
4
-2.80%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-2.80%
Variazione Mensile
0.00%
Variazione di 6 mesi
-31.58%
Variazione Annuale
-40.23%
Chiusura Precedente
1.0
7
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
4
Volume
7
Mercati
Mercato Azionario Statunitense
Salute
COCP
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
5.96 M
8.12 M
8.14 M
10.17 M
10.17 M
—
Valuation ratios
Enterprise value
—
—
-20.2 M
-8.47 M
10.69 M
38.24 M
Price to earnings ratio
—
—
-0.44
-0.94
-1.17
-4.64
Price to sales ratio
—
—
945.49
-260.99
-126.08
-350.54
Price to cash flow ratio
—
—
-0.79
-1.16
-1.25
-4.68
Price to book ratio
—
—
0.43
0.64
2.16
3.33
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.18
-0.18
-0.95
-0.58
1.3
0.46
Return on equity %
0.18
-0.18
-0.98
-0.68
1.84
0.68
Return on invested capital %
186.85
—
1 324.77
2 801.62
2 921.49
—
Gross margin %
100
—
100
100
100
400
Operating margin %
475.97
—
215.72 K
-28.55 K
-10.97 K
96.7 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
479.05
—
-215.76 K
27.67 K
-10.74 K
-58.48 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
25.05
38.4
33.04
8.92
4.77
18.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.05
0
0
-0
-0.01
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.63
-1.52
1.62
-0.31
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
4.57
2.73
0.97
2.82
Net current asset value per share
—
—
4.93
3.01
1.14
3.47
Tangible book value per share
—
—
4.86
2.73
0.94
2.88
Working capital per share
—
—
4.78
2.68
0.9
2.72
Book value per share
—
—
4.86
2.73
0.94
2.88
Notizie
Cocrystal Pharma avanza il candidato farmaco per il norovirus alla fase 1b
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB
Phillip Frost acquista azioni di Cocrystal Pharma (COCP) per 18.812 dollari
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812
Cocrystal Pharma raccoglie 1,03 milioni di dollari in posizionamento privato dai direttori
Cocrystal Pharma raises $1.03 million in private placement from directors
Cocrystal Pharma receives $500,000 NIH grant for influenza drug
Cocrystal Pharma chiude un’offerta diretta registrata di 4,7 milioni di dollari
Cocrystal Pharma closes $4.7 million registered direct offering
Cocrystal Pharma raccoglie 4,7 milioni di dollari tramite offerta diretta
Cocrystal Pharma raises $4.7 million in registered direct offering